Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
Pertuzumab(trade name Perjeta) is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). Pertuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture that may contain the antibiotic, gentamicin. Gentamicin is not detectable in the final product. Pertuzumab has an approximate molecular weight of 148 kDa.
Pertuzumab is supplied at a concentration of 30 mg/mL as a sterile, clear to slightly opalescent, colorless to pale brown liquid of pH approximately 6.0, which contains 20 mM L-histidine acetate, 120 mM sucrose and 0.02% polysorbate 20.
Properties
Name | Pertuzumab |
CAS NO. | 380610-27-5 |
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | HER2 |
Clone | Monoclone |
Molecular Weight | 148 kDa |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China(Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Pertuzumab
